Skip to search.
 TSX Up 0.27% TSX Ventures Up 0.18%

Incyte Corporation (INCY)

-NasdaqGS
89.44 Down 2.22(2.42%) 4:00PM EDT
|After Hours : 89.44 0.00 (0.00%) 4:52PM EDT
Add to Portfolio
Prev Close:91.66
Open:92.30
Bid:89.29 x 100
Ask:89.97 x 200
1y Target Est:91.75
Beta:0.16
Earnings Date:Apr 29 - May 4 (Est.)
Day's Range:87.42 - 92.48
52wk Range:40.30 - 99.00
Volume:1,227,089
Avg Vol (3m):1,211,090
Market Cap:15.36B
P/E (ttm):N/A
EPS (ttm):-0.29
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
INCYDown 2.42%15.36B
AMGNDown 1.72%119.22B
CELGDown 0.62%91.72B
RHHBYUp 0.48%N/A

Key Statistics

Forward P/E (1 yr):89.44
P/S (ttm):30.78
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.25
Quarterly EPS Est (Mar-15) :-0.08
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):-4.37

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics primarily for oncology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback